Total raised
$4.0M
Last: Undisclosed 2023-11
Stage
Seed
Founded
2018
Headcount
15
HQ
Caesarea
Sector
Health Tech & Life Sciences
About
Cannasoul is an Israeli cannabis drug-discovery company developing therapeutics derived from natural compounds. Cannasoul's proprietary analytical platform, data-driven approach, knowhow, and clinical trial framework support active compound identification and development, from botanical extract through clinical approved formulation. Cannasoul has analyzed over 100 cannabinoids and 100 terpenes. The company's subsidiaries include MyPlant Bio, Psyga Bio, Nidra Logic, and CaVnox.
Funding history · 2 rounds · $4.0M total
2023-11
Undisclosed
$4.0M
2018-07
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business model
B2B
Highlights
1 Patents
Tags
pharmaceuticalsmedical-cannabisclinical-trialsdrug-discoverybiotechnologytherapeuticscannabis